Petros Pharmaceuticals, Inc. financial data

Symbol
PTPI on Nasdaq
Industry
Pharmaceutical Preparations
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 96.4 % -54.8%
Quick Ratio 11.1 % -55.1%
Debt-to-equity 528 % +198%
Return On Equity -424 % -516%
Return On Assets -66 % -167%
Operating Margin -346 % -47.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.5M shares +678%
Common Stock, Shares, Outstanding 10.5M shares +252%
Entity Public Float 3.95M USD +25.5%
Common Stock, Value, Issued 1.05K USD +253%
Weighted Average Number of Shares Outstanding, Basic 8.03M shares +269%
Weighted Average Number of Shares Outstanding, Diluted 8.03M shares +269%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.11M USD -12.2%
Research and Development Expense 2.62M USD +8.55%
Operating Income (Loss) -17.7M USD -29.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.3M USD -75.4%
Net Income (Loss) Attributable to Parent -14.3M USD -75.4%
Earnings Per Share, Basic -3.34 USD/shares +47.4%
Earnings Per Share, Diluted -3.34 USD/shares +47.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.71M USD -72.2%
Accounts Receivable, after Allowance for Credit Loss, Current 416K USD -81.3%
Inventory, Net 1.35M USD -16.2%
Other Assets, Current 6.53K USD -94.1%
Assets, Current 7.29M USD -64.2%
Property, Plant and Equipment, Net 22.9K USD -20.8%
Operating Lease, Right-of-Use Asset 114K USD -49.7%
Intangible Assets, Net (Excluding Goodwill) 3.2M USD -64.3%
Other Assets, Noncurrent 294K USD
Assets 10.6M USD -68.5%
Accounts Payable, Current 2.33M USD +35.9%
Accrued Liabilities, Current 6.46M USD +20.6%
Liabilities, Current 18M USD +67.4%
Operating Lease, Liability, Noncurrent 75.2K USD -45.4%
Other Liabilities, Noncurrent 75.2K USD -45.4%
Liabilities 18.1M USD -15.1%
Retained Earnings (Accumulated Deficit) -113M USD -14.5%
Stockholders' Equity Attributable to Parent -7.47M USD -162%
Liabilities and Equity 10.6M USD -68.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.13M USD -51.6%
Net Cash Provided by (Used in) Financing Activities -1.12M USD -213%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 10.5M shares +252%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.26M USD -104%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.71M USD -72.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 142K USD
Deferred Tax Assets, Valuation Allowance 20.4M USD +13%
Operating Lease, Liability 138K USD -47.6%
Lessee, Operating Lease, Liability, to be Paid 163K USD -48.7%
Operating Lease, Liability, Current 62.4K USD -50.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 82.3K USD +1.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 81.1K USD -47.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure +31.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.8K USD -54%
Lessee, Operating Lease, Liability, to be Paid, Year Three 82.3K USD +1.5%
Deferred Tax Assets, Operating Loss Carryforwards 11.9M USD +25.2%
Operating Lease, Payments 189K USD +0.87%
Additional Paid in Capital 106M USD -4.71%
Amortization of Intangible Assets 2.8M USD -14.4%
Depreciation, Depletion and Amortization 2.83M USD -13.8%
Share-based Payment Arrangement, Expense 197K USD -52.7%